Cargando…
Real-World Effectiveness and Risk Factors for Discontinuation of Ustekinumab in Ulcerative Colitis
INTRODUCTION: Ustekinumab (UST) has been approved for the treatment of moderate-to-severe ulcerative colitis (UC). Real-world data showing the effectiveness and safety of UST are necessary to confirm the results of clinical trials for applicability in daily clinical practice. Although some studies h...
Autores principales: | Uchida, Genta, Nakamura, Masanao, Yamamura, Takeshi, Maeda, Keiko, Sawada, Tsunaki, Ishikawa, Eri, Furukawa, Kazuhiro, Iida, Tadashi, Mizutani, Yasuyuki, Yamao, Kentaro, Ishikawa, Takuya, Ishizu, Yoji, Honda, Takashi, Ishigami, Masatoshi, Kawashima, Hiroki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10601947/ https://www.ncbi.nlm.nih.gov/pubmed/37901340 http://dx.doi.org/10.1159/000531497 |
Ejemplares similares
-
Clinical characteristics of Dieulafoy’s lesion in the small bowel diagnosed and treated by double-balloon endoscopy
por: Nakamura, Masanao, et al.
Publicado: (2023) -
The effects of ustekinumab on small intestinal lesions and stenotic lesions
por: Wada, Hirotaka, et al.
Publicado: (2022) -
Gelsolin as a Potential Biomarker for Endoscopic Activity and Mucosal Healing in Ulcerative Colitis
por: Maeda, Keiko, et al.
Publicado: (2022) -
Analysis of immunologic comorbidities in ulcerative colitis patients: a tool to prevent exacerbations in ulcerative colitis cases
por: Rodríguez Meza, Miguel Ricardo, et al.
Publicado: (2022) -
Clinical Features of Ischemic Enteritis Diagnosed by Double-Balloon Endoscopy
por: Nakamura, Masanao, et al.
Publicado: (2021)